US Patent 8497295 Spiroindoline modulators of muscarinic receptors
Patent 8497295 was granted and assigned to Vertex Pharmaceuticals on July, 2013 by the United States Patent and Trademark Office.
All edits
Edits on 12 Mar, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 21 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 08497295 Spiroindoline modulators of muscarinic receptors US Patent 8497295 Spiroindoline modulators of muscarinic receptors
Infobox
Patent Number
084972950
Patent Number
84972950
Edits on 22 Apr, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
084972950
Date of Patent
July 30, 2013
0Patent Application Number
135461850
Date Filed
July 11, 2012
0Patent Primary Examiner
Edits on 17 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 08497295 Spiroindoline modulators of muscarinic receptors
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
08497295
Date of patent
July 30, 2013
Patent application number
13546185
Date Filed
July 11, 2012
Patent primary examiner
Find more entities like US Patent 8497295 Spiroindoline modulators of muscarinic receptors
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
